Sarah Weltz

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Targeting Mitochondria with ClpP Agonists as a Novel Therapeutic Opportunity in Breast Cancer”.

Targeting Mitochondria with ClpP Agonists as a Novel Therapeutic Opportunity in Breast Cancer

Cancers(2023)10.3390/cancers15071936

N/A

0DataRank · unranked

33 citations

Yoshimi Endo Greer, David Wisniewski, Sarah Weltz, Manjari Kundu, Donna Voeller +2 more

TRAIL-induced cytokine production via NFKB2 pathway promotes neutrophil chemotaxis and immune suppression in triple negative breast cancers

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.07.19.604341

N/A

0DataRank · unranked

3 citations

Yoshimi Endo Greer, Alexei Lobanov, Lisa A. Ridnour, Renee N. Donahue, Yeap Ng +11 more

TRAIL induces cytokine production via the NFkB2 pathway promoting neutrophil chemotaxis and neutrophil-mediated immune-suppression in triple negative breast cancer cells

Cancer Letters(2025)10.1016/j.canlet.2025.217692

N/A

0DataRank · unranked

10 citations

Yoshimi Endo Greer, Alexei Lobanov, Lisa A. Ridnour, Renee N. Donahue, Yeap Ng +12 more